Tumor-associated macrophages were also profiled, and an increased M1 (phagocytic, CD206-CD86+)/M2 (proinflammatory, CD206+CD86−) ratio was observed (Fig. 5e and Supplementary Fig. 11b). The gene discussed is CD86; the disease is neoplasm.